Instylla

Instylla is a clinical-stage company based in Bedford, Massachusetts, United States, that focuses on developing next-generation liquid embolics for interventional radiology, with initial applications in interventional oncology and peripheral hemostasis. The company is currently conducting a pivotal study for their hypervascular tumor treatment.